LAVQX | VVIAX | LAVQX / VVIAX | |
Total Expense Ratio | N/A | N/A | - |
Annual Report Gross Expense Ratio | N/A | N/A | - |
Fund Existence | 17 years | 24 years | - |
Gain YTD | 21.742 | 18.917 | 115% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 0 | 3000 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 2.01B | 186B | 1% |
Annual Yield % from dividends | 0.46 | 2.36 | 19% |
Returns for 1 year | 33.19 | 29.17 | 114% |
Returns for 3 years | 10.29 | 26.69 | 39% |
Returns for 5 years | 33.16 | 59.39 | 56% |
Returns for 10 years | 11.34 | 128.75 | 9% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
MFLDX | 23.57 | 0.04 | +0.17% |
Cromwell Long Short Institutional | |||
RAFBX | 37.66 | 0.03 | +0.08% |
American Funds AMCAP R2 | |||
ERHSX | 16.38 | -0.03 | -0.18% |
Eaton Vance Worldwide Health Sci R | |||
TSCHX | 20.78 | -0.05 | -0.24% |
Nuveen Quant Small Cap Equity I | |||
HERIX | 10.63 | -0.07 | -0.65% |
Hartford Emerging Markets Equity I |